000 | 01004 a2200277 4500 | ||
---|---|---|---|
005 | 20250516061611.0 | ||
264 | 0 | _c20111108 | |
008 | 201111s 0 0 eng d | ||
022 | _a1699-3993 | ||
024 | 7 |
_a10.1358/dot.2011.47.5.1579112 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFiuzat, M | |
245 | 0 | 0 |
_aBucindolol: new hopes from reviewing past data. _h[electronic resource] |
260 |
_bDrugs of today (Barcelona, Spain : 1998) _cMay 2011 |
||
300 |
_a347-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xtherapeutic use |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPropanolamines _xmetabolism |
700 | 1 | _aO'Connor, C M | |
773 | 0 |
_tDrugs of today (Barcelona, Spain : 1998) _gvol. 47 _gno. 5 _gp. 347-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1358/dot.2011.47.5.1579112 _zAvailable from publisher's website |
999 |
_c21245543 _d21245543 |